212 related articles for article (PubMed ID: 14619610)
21. Diabetes mellitus as a prothrombotic condition.
Grant PJ
J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
[TBL] [Abstract][Full Text] [Related]
22. Coagulation and fibrinolysis in diabetes.
Banga JD
Semin Vasc Med; 2002 Feb; 2(1):75-86. PubMed ID: 16222598
[TBL] [Abstract][Full Text] [Related]
23. [Influence polyunsaturated fatty acids omega-3 on coagulation and fibrinolysis systems in patients with NIDDM].
Panchenko VM; Karabasova MA; Liutova LV; Togoev AM; Ershov AA; Chernova GI; Isaev VA
Klin Med (Mosk); 2002; 80(2):40-3. PubMed ID: 11898721
[TBL] [Abstract][Full Text] [Related]
24. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
25. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
[TBL] [Abstract][Full Text] [Related]
26. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
Stehling F; Weber R; Ozcelik A; Bröcker M; Volbracht L; Diener HC; Busch E
Neurosci Lett; 2008 Aug; 441(1):39-43. PubMed ID: 18597942
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the pro-thrombotic state in CAPD patients.
Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
[TBL] [Abstract][Full Text] [Related]
28. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
29. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
30. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
[TBL] [Abstract][Full Text] [Related]
31. [The use of the combined food products with soy protein in diet therapy for patients with diabetes mellitus type 2].
Meshcheriakova VA; Plotnikova OA; Sharafetdinov KhKh; Iatsyshina TA
Vopr Pitan; 2002; 71(5):19-24. PubMed ID: 12599994
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
33. Estrogen treatment improves arterial distensibility, fibrinolysis, and metabolic profile in postmenopausal women with type 2 diabetes mellitus.
Sztejnsznajd C; Silva ME; Nussbacher A; Gebara OE; D'Amico EA; Rocha DM; da Rocha TR; Santos RF; Wajngarten M; Fukui RT; Correia MR; Wajchenberg BL; Ursich MJ
Metabolism; 2006 Jul; 55(7):953-9. PubMed ID: 16784970
[TBL] [Abstract][Full Text] [Related]
34. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
Liu BY; Jian YL; Zhong M; Yu YH; Wang Q; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):35-7. PubMed ID: 17259140
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
Vague P; Juhan-Vague I
Diabetologia; 1997 Jun; 40(6):738-40. PubMed ID: 9222657
[No Abstract] [Full Text] [Related]
36. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
[TBL] [Abstract][Full Text] [Related]
37. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Hemelaar M; Kenemans P; Hack CE; Klipping C; van der Mooren MJ
Menopause; 2008; 15(2):248-55. PubMed ID: 17693902
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
[TBL] [Abstract][Full Text] [Related]
39. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
Wycherley TP; Brinkworth GD; Noakes M; Buckley JD; Clifton PM
Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
[TBL] [Abstract][Full Text] [Related]
40. [Effect of food diet supplements with chromium on the clinical and metabolic parameters in type 2 diabetic patients].
Sharafetdinov KhKh; Meshcheriakova VA; Plotnikova OA; Mazo VK; Gmoshinskiĭ IV; Nechaeva SV
Vopr Pitan; 2004; 73(5):17-20. PubMed ID: 15754482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
